361 related articles for article (PubMed ID: 36252483)
1. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
[TBL] [Abstract][Full Text] [Related]
2. Regorafenib-Attenuated, Bleomycin-Induced Pulmonary Fibrosis by Inhibiting the TGF-β1 Signaling Pathway.
Li X; Ma L; Huang K; Wei Y; Long S; Liu Q; Zhang D; Wu S; Wang W; Yang G; Zhou H; Yang C
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671452
[TBL] [Abstract][Full Text] [Related]
3. Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway.
Gu S; Liang J; Zhang J; Liu Z; Miao Y; Wei Y; Li S; Gu J; Cui Y; Xiao T; Li X; Yang C
Molecules; 2023 Feb; 28(5):. PubMed ID: 36903446
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
[TBL] [Abstract][Full Text] [Related]
5. Bergenin attenuates bleomycin-induced pulmonary fibrosis in mice via inhibiting TGF-β1 signaling pathway.
Li X; Wang Y; Liang J; Bi Z; Ruan H; Cui Y; Ma L; Wei Y; Zhou B; Zhang L; Zhou H; Yang C
Phytother Res; 2021 Oct; 35(10):5808-5822. PubMed ID: 34375009
[TBL] [Abstract][Full Text] [Related]
6. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
Ruan H; Gao S; Li S; Luan J; Jiang Q; Li X; Yin H; Zhou H; Yang C
Molecules; 2021 May; 26(9):. PubMed ID: 34068694
[TBL] [Abstract][Full Text] [Related]
7. Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway.
Miao Y; Li X; Yang Y; Zhang J; Chen L; Zhang Q; Li W; Liu Y; Zhang X; Gu R; Yang C
Int Immunopharmacol; 2022 Dec; 113(Pt B):109427. PubMed ID: 36375321
[TBL] [Abstract][Full Text] [Related]
8. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
10. Fedratinib Attenuates Bleomycin-Induced Pulmonary Fibrosis via the JAK2/STAT3 and TGF-β1 Signaling Pathway.
Ruan H; Luan J; Gao S; Li S; Jiang Q; Liu R; Liang Q; Zhang R; Zhang F; Li X; Zhou H; Yang C
Molecules; 2021 Jul; 26(15):. PubMed ID: 34361644
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice.
Miao Y; Wang Y; Bi Z; Huang K; Gao J; Li X; Li S; Wei L; Zhou H; Yang C
BMC Pulm Med; 2023 Mar; 23(1):94. PubMed ID: 36949426
[TBL] [Abstract][Full Text] [Related]
12. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
13. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
[TBL] [Abstract][Full Text] [Related]
14. Silencing lncRNA Snhg6 mitigates bleomycin-induced pulmonary fibrosis in mice via miR-26a-5p/TGF-β1-smads axis.
Deng W; Zhang Y; Fang P; Shi H; Yang S
Environ Toxicol; 2022 Oct; 37(10):2375-2387. PubMed ID: 35785413
[TBL] [Abstract][Full Text] [Related]
15. Eupatilin inhibits pulmonary fibrosis by activating Sestrin2/PI3K/Akt/mTOR dependent autophagy pathway.
Gong H; Lyu X; Liu Y; Peng N; Tan S; Dong L; Zhang X
Life Sci; 2023 Dec; 334():122218. PubMed ID: 37918625
[TBL] [Abstract][Full Text] [Related]
16. Transforming Growth Factor-β1 Regulates Peroxisomal Genes/Proteins via Smad Signaling in Idiopathic Pulmonary Fibrosis Fibroblasts and Transgenic Mouse Models.
Oruqaj G; Karnati S; Kotarkonda LK; Boateng E; Bartkuhn M; Zhang W; Ruppert C; Günther A; Bartholin L; Shi W; Baumgart-Vogt E
Am J Pathol; 2023 Mar; 193(3):259-274. PubMed ID: 36521562
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway.
Xue L; Deng D; Zheng S; Tang M; Yang Z; Pei H; Chen Y; Yang T; Liu K; Ye H; Chen L
Eur J Med Chem; 2020 Jul; 197():112259. PubMed ID: 32334267
[TBL] [Abstract][Full Text] [Related]
18. Duvelisib attenuates bleomycin-induced pulmonary fibrosis via inhibiting the PI3K/Akt/mTOR signalling pathway.
Li X; Ma X; Miao Y; Zhang J; Xi B; Li W; Zhang Q; Chen L; Yang Y; Li H; Wei L; Zhou H; Yang C
J Cell Mol Med; 2023 Feb; 27(3):422-434. PubMed ID: 36651446
[TBL] [Abstract][Full Text] [Related]
19. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
[TBL] [Abstract][Full Text] [Related]
20. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
